{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T08:03:55Z","timestamp":1768637035906,"version":"3.49.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"52","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.vaccine.2018.10.098","type":"journal-article","created":{"date-parts":[[2018,11,16]],"date-time":"2018-11-16T02:51:59Z","timestamp":1542336719000},"page":"7993-8000","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Serotypes and genotypes of S. pneumoniae isolates from adult invasive disease in Spain: A 5-year prospective surveillance after pediatric PCV13 licensure. The ODIN study"],"prefix":"10.1016","volume":"36","author":[{"given":"Asunci\u00f3n","family":"Fenoll","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0225-607X","authenticated-orcid":false,"given":"Carmen","family":"Ardanuy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josefina","family":"Li\u00f1ares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilia","family":"Cercenado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesc","family":"Marco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Fleites","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Rodr\u00edguez-Mayo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose-Luis","family":"L\u00f3pez-Hontangas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bego\u00f1a","family":"Palop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana-Isabel","family":"Aller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Buenaventura","family":"Buend\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"M\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Cifuentes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.10.098_b0005","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1473-3099(05)70083-9","article-title":"Epidemiological differences among pneumococcal serotypes","volume":"5","author":"Hausdorff","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2018.10.098_b0010","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1128\/CMR.00024-15","article-title":"Pneumococcal capsules and their types: past, present, and future","volume":"28","author":"Geno","year":"2015","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2018.10.098_b0015","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/INF.0b013e31824de9f6","article-title":"The worldwide impact of the seven-valent pneumococcal conjugate vaccine","volume":"31","author":"Fitzwater","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2018.10.098_b0020","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.vaccine.2014.11.011","article-title":"Impact of the pneumococcal conjugate vaccines on invasive pneumococcal disease in France, 2001\u20132012","volume":"33","author":"Lepoutre","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.10.098_b0025","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1128\/CVI.00317-10","article-title":"Relationship between serotypes, age, and clinical presentation of invasive pneumococcal disease in Madrid, Spain, after introduction of the 7-valent pneumococcal conjugate vaccine into the vaccination calendar","volume":"18","author":"Picazo","year":"2011","journal-title":"Clin Vacc Immunol CVI"},{"key":"10.1016\/j.vaccine.2018.10.098_b0030","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1473-3099(15)70044-7","article-title":"Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study","volume":"15","author":"Waight","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2018.10.098_b0035","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jinf.2016.01.011","article-title":"Declining mortality from adult pneumococcal infections linked to children's vaccination","volume":"72","author":"Grau","year":"2016","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2018.10.098_b0040","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1086\/648593","article-title":"Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine","volume":"201","author":"Pilishvili","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.10.098_b0045","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1016\/j.vaccine.2016.03.052","article-title":"Impact of pneumococcal vaccination in children on serotype distribution in adult community-acquired pneumonia using the serotype-specific multiplex urinary antigen detection assay","volume":"34","author":"Pletz","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.10.098_b0050","unstructured":"Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23). MMWR Morbid Mortal Week Rep 2010;59:1102\u20136."},{"key":"10.1016\/j.vaccine.2018.10.098_b0055","doi-asserted-by":"crossref","first-page":"5691","DOI":"10.1016\/j.vaccine.2015.08.009","article-title":"Secular trends (1990\u20132013) in serotypes and associated non-susceptibility of S. pneumoniae isolates causing invasive disease in the pre-\/post-era of pneumococcal conjugate vaccines in Spanish regions without universal paediatric pneumococcal vaccination","volume":"33","author":"Fenoll","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.10.098_b0060","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1128\/JCM.39.7.2565-2571.2001","article-title":"Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology network","volume":"39","author":"McGee","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2018.10.098_b0065","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1099\/00221287-144-11-3049","article-title":"A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease","volume":"144","author":"Enright","year":"1998","journal-title":"Microbiology"},{"key":"10.1016\/j.vaccine.2018.10.098_b0070","series-title":"Performance standards for antimicrobial susceptibility testing: nineteenth informational supplement M100-S19","author":"Clinical Laboratory Standasds Institute (CLSI)","year":"2009"},{"key":"10.1016\/j.vaccine.2018.10.098_b0075","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/INF.0b013e318247ef84","article-title":"Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal nasopharyngeal carriage in children with acute otitis media","volume":"31","author":"Cohen","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2018.10.098_b0080","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1097\/INF.0000000000000697","article-title":"Genetic analysis of invasive pneumococcal isolates from children in Ontario, Canada, 2007\u20132012","volume":"34","author":"Deng","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2018.10.098_b0085","doi-asserted-by":"crossref","first-page":"e0151125","DOI":"10.1371\/journal.pone.0151125","article-title":"Serotypes and clonal diversity of streptococcus pneumoniae causing invasive disease in the era of PCV13 in Catalonia, Spain","volume":"11","author":"Del Amo","year":"2016","journal-title":"PloS one"},{"key":"10.1016\/j.vaccine.2018.10.098_b0090","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/INF.0000000000000279","article-title":"Direct and indirect effects of PCV13 on nasopharyngeal carriage of PCV13 unique pneumococcal serotypes in Massachusetts' children","volume":"33","author":"Loughlin","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2018.10.098_b0095","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/j.vaccine.2016.01.038","article-title":"The potential role of 13-valent pneumococcal conjugate vaccine in preventing respiratory complications in bacteraemic pneumococcal community-acquired pneumonia","volume":"34","author":"Sanz-Herrero","year":"2016","journal-title":"Vaccine"},{"issue":"111\u20135","key":"10.1016\/j.vaccine.2018.10.098_b0100","first-page":"e1","article-title":"Bacteremic pneumonia before and after withdrawal of 13-valent pneumococcal conjugate vaccine from a public vaccination program in Spain: a case-control study","volume":"171","author":"Tagarro","year":"2016","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2018.10.098_b0105","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1086\/374624","article-title":"Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential","volume":"187","author":"Brueggemann","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.10.098_b0110","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1093\/cid\/cis971","article-title":"Epidemiology of invasive pneumococcal disease among high-risk adults since the introduction of pneumococcal conjugate vaccine for children","volume":"56","author":"Muhammad","year":"2013","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.vaccine.2018.10.098_b0115","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/cid\/civ803","article-title":"Invasive pneumococcal disease among immunocompromised persons: implications for vaccination programs","volume":"62","author":"Shigayeva","year":"2016","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.vaccine.2018.10.098_b0120","first-page":"822","article-title":"Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged >\/=65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"63","author":"Tomczyk","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2018.10.098_b0125","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1080\/21645515.2015.1102811","article-title":"Pneumococcal serotype distribution in adults with invasive disease and in carrier children in Italy: should we expect herd protection of adults through infants' vaccination?","volume":"12","author":"Azzari","year":"2016","journal-title":"Human Vacc Immunotherap"},{"key":"10.1016\/j.vaccine.2018.10.098_b0130","first-page":"402","article-title":"Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period","volume":"16","author":"Linares","year":"2010","journal-title":"Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2018.10.098_b0135","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.3201\/eid2011.131215","article-title":"Spread of Streptococcus pneumoniae serotype 8-ST63 multidrug-resistant recombinant Clone, Spain","volume":"20","author":"Ardanuy","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2018.10.098_b0140","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1128\/AAC.02669-13","article-title":"Fluoroquinolone-resistant pneumococci: dynamics of serotypes and clones in Spain in 2012 compared with those from 2002 and 2006","volume":"58","author":"Domenech","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.vaccine.2018.10.098_b0145","first-page":"1094","article-title":"Multidrug-resistant pneumococci (serotype 8) causing invasive disease in HIV+ patients","volume":"17","author":"Sanz","year":"2011","journal-title":"Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2018.10.098_b0150","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1086\/505710","article-title":"Capsular serotype-specific attack rates and duration of carriage of Streptococcus pneumoniae in a population of children","volume":"194","author":"Sleeman","year":"2006","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18314956?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18314956?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T16:45:05Z","timestamp":1550594705000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18314956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":30,"journal-issue":{"issue":"52","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S0264410X18314956"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.10.098","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serotypes and genotypes of S. pneumoniae isolates from adult invasive disease in Spain: A 5-year prospective surveillance after pediatric PCV13 licensure. The ODIN study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.10.098","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}